CSAM: CSAM Health Group AS to acquire Fertsoft AB
2020-12-18 20:49:54
Oslo, Norway, December 18, 2020: CSAM Health Group AS ("CSAM"), the leading
provider of niche eHealth solutions in the Nordics, today announced that they
have entered into a Share Purchase Agreement for the acquisition of all shares
in Fertsoft AB ("Fertsoft").
With the acquisition of Fertsoft, CSAM has created a comprehensive portfolio of
women and children's healthcare solutions - ranging from conception to early
childhood - and further strengthened its position.
Fertsoft, founded in 2010, provides complete care and practice management
software for Assisted Reproductive Technology (ART) clinics. The company is
headquartered in Uppsala, Sweden and serves customers across the Nordics and
Europe.
- The acquisition of Fertsoft allows CSAM to expand our already leading
portfolio of solutions in women and children's health, adding our first-ever
software solutions within the growing ART market, said Sverre Flatby, CSAM CEO.
- Fertsoft and CSAM share a commitment to enabling excellent care through the
delivery of highly specialised eHealth solutions, said Martin Björkman, Chief
Developer and CEO of Fertsoft. - I am confident that Fertsoft will find a great
home at CSAM, allowing us to grow our reach to new customers and markets, and
ultimately helping more people realise their dream of having a child.
Fertsoft reported annual sales of ca 4.8 MSEK for its deviating accounting year
that ended June 30, 2020. The agreed purchase price is 6 MSEK, and will be
settled through an issue of shares in CSAM Health Group AS.
The transaction is expected to close later this month.
For more information, contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com
About CSAM
CSAM has established itself as a leading Nordic niche player in the specialised
eHealth market with a unique blend of best-in-class innovative technology, and
outstanding human skills. The company's diverse portfolio of software solutions
enables healthcare providers to access relevant clinical information at the
point of care. CSAM's commercial headquarters are located in Oslo, Norway. The
company also has local offices in Stockholm, Karlstad, Gothenburg, Copenhagen,
Helsinki, Oulu, Tampere, Tromsø and Warwickshire, as well as a wholly owned
software engineering subsidiary in the Philippines.
For more information, visit www.csamhealth.com.